top of page
Recent Posts
See AllRakovina Therapeutics’ management will deliver a brief corporate overview and then be available for questions and discussions...
Pre-clinical studies show potential synergy in treatment of solid tumors by combining a PARP inhibitor with inhibition of HDAC enzymes.
bottom of page